Sequenom Announces New Positive Data on Down Syndrome Detection and – PR Inside

Sequenom Announces New Positive Data on Down Syndrome Detection and – PR Inside
Sequenom, Inc. (NASDAQ:SQNM) today announced new positive data from the prospective clinical studies using the Company’s noninvasive SEQureDx” technology, enabling the detection of fetal aneuploidy from maternal blood. The data presented today

Speak Your Mind